RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan
Clinical trial NCT03745157 · COMPLETED
Trial details
- NCT number
- NCT03745157
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-21
- Primary completion
- 2019-10-29
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.